Mr. Calafiore’s will step down Aug. 31 and take over as CEO of an unnamed orthopedic medtech company, according to a news release. His responsibilities will be reallocated across NuVasive management.
“In my five years at NuVasive, I am very proud of our collective work to transform surgery, advance care and, most importantly, change the lives of patients around the world,” Mr. Calafiore said in the release.
